Clinical Trial Update: ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for ACE Reno and Pico Cell Matrix evaluating effects on estimated glomerular filtration rate in chronic kidney disease. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases
• Chronic Kidney Disease
• Diabetic Nephropathy
• Hypertensive Nephropathy
• Microalbuminuria

Drugs mentioned

• ACE Reno
• Pico Cell Matrix

Snippet

Sponsor: Ace Cells Lab Limited | Conditions: Hypertensive Nephropathy, Auto Immune Disorders | Phase 4 | Status: RECRUITING